KELLY MIKE: Open Payments
NPI 1073939468 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,909 in 87 payments from 6 companies in 2025. Trend: 2023 $32 · 2024 $399 · 2025 $3,909
Consulting: $1,860Food & beverage: $1,791Travel & lodging: $258
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 32 | $2,972 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 39 | $610 |
| ABBVIE INC. | 9 | $163 |
| ViiV Healthcare Company | 5 | $129 |
| Novo Nordisk Inc | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Epclusa, XIFAXAN, MAVYRET, APRETUDE, CABENUVA, Wegovy, REXULTI.
Industry payments across KY — which companies pay providers there.
